Boston, MA, United States of America

Julianne Glowacki


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Jamaica Plain, MA (US) (2014)
  • Boston, MA (US) (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Bone Healing by Julianne Glowacki

Introduction

Julianne Glowacki is an accomplished inventor based in Boston, MA, known for her significant contributions to the field of bone healing. With a total of two patents to her name, she has developed innovative methods and compounds aimed at accelerating the healing process for individuals with bone damage.

Latest Patents

Her latest patents include groundbreaking work on compounds for bone healing. These patents disclose methods for accelerating bone healing in subjects, which involve administering specific compounds to individuals at risk of or suffering from bone damage. The methods can be applied both prophylactically and after bone damage has occurred. Additionally, she has developed targeted nitroxide agents that are useful for enhancing bone healing and growth. These compounds feature a nitroxide-containing group linked to a mitochondria-targeting group, allowing for effective cross-linking into dimers without losing their activity.

Career Highlights

Julianne has worked with prestigious institutions such as the University of Pittsburgh and Brigham and Women's Hospital, Inc. Her work has been instrumental in advancing the understanding and treatment of bone-related injuries.

Collaborations

Throughout her career, Julianne has collaborated with notable colleagues, including Michael Wayne Epperly and Joel S. Greenberger. These partnerships have further enriched her research and innovations in the field.

Conclusion

Julianne Glowacki's contributions to bone healing through her innovative patents and collaborations highlight her role as a leading inventor in this critical area of medical research. Her work continues to pave the way for advancements in treatment options for patients with bone damage.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…